Urinary tract infections and Urolithiasis

被引:9
作者
Meissner, A. [1 ]
Mamoulakis, C. [1 ,2 ]
Laube, N. [3 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Crete, Sch Med, Dept Urol, Iraklion, Greece
[3] Univ Bonn, Akad Lehrzentrum, Deutsch Harnsteinzentrum, Med Zentrum, D-5300 Bonn, Germany
来源
UROLOGE | 2010年 / 49卷 / 05期
关键词
Urinary tract infection; Urolithiasis; Struvite; Therapy; STONE ANALYSES; BIOFILM; STENTS;
D O I
10.1007/s00120-010-2257-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The classic "infection stone" struvite is formed as a result of metabolic activity of urease-positive bacteria from alkaline urine with pH-values above 7.5. Due to improved infection diagnostics and antibiotic therapy, the occurrence of infection-related urinary stones in the western industrialized world decreases, despite the generally increasing prevalence rates of urolithiasis in these societies. Struvite is often associated with other mineral phases. These accessory mineral phases could indicate other, non-infection-related causes of urinary stone formation. Thus, mineral analysis is always recommended. Struvite stones as well as struvite encrustations on urinary tract implants are characterized by rapid growth. The rapid growth-related embedding of urease-positive bacteria in the crystalline material makes the urinary stone a persistent source of recurrent urinary tract infections. According to the German Society of Urology guidelines on urolithiasis, a patient with the diagnosis "infection stone" should be assigned to the "high-risk" patient group. Complete stone and debris removal, as well as a special metaphylaxis strategy are required to initiate successful stone therapy.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 24 条
[1]  
*ARB HARNST AK DTS, 2009, LEITL DIAGN THER MET
[2]  
BERG W, 1992, UROLOGE A, V31, P98
[3]  
Bichler KH, 2003, UROLOGE A, V42, P47, DOI 10.1007/s00120-002-0272-5
[4]   Urinary infection stones [J].
Bichler, KH ;
Eipper, E ;
Naber, K ;
Braun, V ;
Zimmermann, R ;
Lahme, S .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (06) :488-498
[5]  
Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365
[6]   Eliminating biofilm from ureteral stents: the holy grail [J].
Denstedt, John D. ;
Cadieux, Peter A. .
CURRENT OPINION IN UROLOGY, 2009, 19 (02) :205-210
[7]  
Flemming H.-C., 2000, Biofilms: recent advances in their study and control, P19, DOI DOI 10.1201/9781482293968
[8]  
Grabe M., 2009, Guidelines on urological infections
[9]   ACETOHYDROXAMIC ACID - CLINICAL STUDIES OF A UREASE INHIBITOR IN PATIENTS WITH STAGHORN RENAL CALCULI [J].
GRIFFITH, DP ;
GIBSON, JR ;
CLINTON, CW ;
MUSHER, DM .
JOURNAL OF UROLOGY, 1978, 119 (01) :9-15
[10]   STRUVITE STONES [J].
GRIFFITH, DP .
KIDNEY INTERNATIONAL, 1978, 13 (05) :372-382